BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22393119)

  • 1. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement.
    Wolford A; McDonald TS; Eng H; Hansel S; Chen Y; Bauman J; Sharma R; Kalgutkar AS
    Drug Metab Dispos; 2012 Jun; 40(6):1067-75. PubMed ID: 22393119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole.
    Buchanan JA; Lavonas EJ
    Curr Opin Hematol; 2012 Jan; 19(1):27-31. PubMed ID: 22143075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole: a dangerous new cocaine adulterant.
    Chang A; Osterloh J; Thomas J
    Clin Pharmacol Ther; 2010 Sep; 88(3):408-11. PubMed ID: 20668440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of levamisole in urine by gas chromatography-mass spectrometry.
    Trehy ML; Brown DJ; Woodruff JT; Westenberger BJ; Nychis WG; Reuter N; Schier JG; Vagi SJ; Hwang RJ
    J Anal Toxicol; 2011 Oct; 35(8):545-50. PubMed ID: 22004673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.
    Czuchlewski DR; Brackney M; Ewers C; Manna J; Fekrazad MH; Martinez A; Nolte KB; Hjelle B; Rabinowitz I; Curtis BR; McFarland JG; Baumbach J; Foucar K
    Am J Clin Pathol; 2010 Mar; 133(3):466-72. PubMed ID: 20154286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole in cocaine: unexpected news from an old acquaintance.
    Larocque A; Hoffman RS
    Clin Toxicol (Phila); 2012 Apr; 50(4):231-41. PubMed ID: 22455354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Agranulocytosis and vasculitis in a cocaine addict: levamisole, the hidden culprit].
    Lemaignen A; Goulenok T; Kalamarides S; Plat A; Pfau G; Fantin B
    Rev Med Interne; 2014 Oct; 35(10):676-9. PubMed ID: 24290029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge.
    Lee KC; Ladizinski B; Federman DG
    Mayo Clin Proc; 2012 Jun; 87(6):581-6. PubMed ID: 22677078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A warning about agranulocytosis with the use of cocaine adulterated with levamisole.
    Perkisas S; Vrelust I; Martin M; Gadisseur A; Schroyens W
    Acta Clin Belg; 2011; 66(3):226-7. PubMed ID: 21837934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature.
    Gaertner EM; Switlyk SA
    Cutis; 2014 Feb; 93(2):102-6. PubMed ID: 24605347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis after cocaine use: a case of suspected levamisole contamination in Belgium.
    Brabant W; Mazure D; Vantilborgh A; van Heeringen C; Lemmens GM
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1159-60. PubMed ID: 22770727
    [No Abstract]   [Full Text] [Related]  

  • 12. Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome.
    Mouzakis J; Somboonwit C; Lakshmi S; Rumbak M; Sinnott J; Cherpelis B; Keshishian J
    J Drugs Dermatol; 2011 Oct; 10(10):1204-7. PubMed ID: 21968674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole.
    Buchanan JA; Oyer RJ; Patel NR; Jacquet GA; Bornikova L; Thienelt C; Shriver DA; Shockley LW; Wilson ML; Hurlbut KM; Lavonas EJ
    J Med Toxicol; 2010 Jun; 6(2):160-4. PubMed ID: 20358411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranulocytosis from levamisole-adulterated cocaine.
    Caldwell KB; Graham OZ; Arnold JJ
    J Am Board Fam Med; 2012; 25(4):528-30. PubMed ID: 22773721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients.
    Friend K; Milone MC; Perrone J
    Ann Emerg Med; 2012 Jul; 60(1):94-6. PubMed ID: 21958733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis associated with cocaine use - four States, March 2008-November 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(49):1381-5. PubMed ID: 20019655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Levamisole-Induced Agranulocytosis Complicated by Bowel Ischemia in a Cocaine User.
    Khan MS; Khan Z; Khateeb F; Moustafa A; Taleb M; Yoon Y
    Am J Case Rep; 2018 Jun; 19():630-633. PubMed ID: 29853712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole-adulterated in cocaine causing agranulocytosis, vasculopathy, and acquired protein S deficiency.
    Dy I; Pokuri V; Olichney J; Wiernik P
    Ann Hematol; 2012 Mar; 91(3):477-8. PubMed ID: 21773730
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of levamisole in cocaine users: a review and risk assessment.
    Brunt TM; van den Berg J; Pennings E; Venhuis B
    Arch Toxicol; 2017 Jun; 91(6):2303-2313. PubMed ID: 28314885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of cocaine-associated agranulocytosis.
    Buxton JA; Omura J; Kuo M; Ross C; Tzemis D; Purssell R; Gardy J; Carleton B
    BMC Res Notes; 2015 Jun; 8():240. PubMed ID: 26070312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.